VanEck Pharmaceutical ETF
86 hedge funds and large institutions have $416M invested in VanEck Pharmaceutical ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 91 → 86 (-5)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Holders
86
Holding in Top 10
2
Calls
$7.4M
Puts
$410K
Top Buyers
| 1 | +$117M | |
| 2 | +$4.14M | |
| 3 | +$3.4M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.16M |
| 5 |
LPL Financial
San Diego,
California
|
+$2.07M |
Top Sellers
| 1 | -$5.6M | |
| 2 | -$2.46M | |
| 3 | -$2.2M | |
| 4 |
LJAC
L.J. Altfest & Co
New York
|
-$764K |
| 5 |
NL
NVWM LLC
Yardley,
Pennsylvania
|
-$751K |